MedPath

A clinical trial to study the effect of the drug Athimathura chooranam and Ayilpattai pattru in patients having Venpulli(Vitiligo)

Phase 2
Not yet recruiting
Conditions
Vitiligo,
Registration Number
CTRI/2019/11/022102
Lead Sponsor
Government siddha medical college
Brief Summary

This is an phase II open single group non randomized study to evaluate the official siddha formulation Athimathura chooranam(Int)& Ayilpattai pattru (Ext) for venpulli (Vitiligo).The trial drug is given 0.5 - 1 gm twice  a day for 48 days & Ayilpattai pattru externally for 48 days .Clinical trial conducted after conducting preclinical toxicity study. The trial drug Athimathura chooranam and Ayilpattai pattru is mentioned in Gunapadam Mooligai.During the trial ,study related data will be recorded and documented. After the completion of trial all the data will be analysed statistically

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

12 years Both Male and female children Hypo pigmented patches surrounded by hyper pigmented border present in any part of the body.

Exclusion Criteria

Age below 4 years Albinism Piebaldsim Depigmented patches occurred after burns Hypopigmented patches starts firstly in lips,Genital area Juveline diabetes with vitiligo.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
It is mainly assessed by reduction in VASI score48 days
Photos of the patient before and after treatment for the clinical improvement48 days
Secondary Outcome Measures
NameTimeMethod
It is assessed by comparing the safety parameters before and after treatment48 days

Trial Locations

Locations (1)

Arignar Anna hospital of indian medicine

🇮🇳

Chennai, TAMIL NADU, India

Arignar Anna hospital of indian medicine
🇮🇳Chennai, TAMIL NADU, India
DrGArthi
Principal investigator
9597298671
oviya.vaithiyanathan@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.